UPDATE: Roth Capital Downgrades Apellis Pharmaceuticals (APLS) to Sell
Tweet Send to a Friend
(Updated - April 14, 2022 4:06 AM EDT)
Roth Capital analyst Elemer Piros downgraded Apellis Pharmaceuticals (NASDAQ: APLS) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Roth Capital analyst Elemer Piros downgraded Apellis Pharmaceuticals (NASDAQ: APLS) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
